Nanomedical system for nucleic acid drugs created with the biodegradable nanoparticle platform

Journal of Microencapsulation

Volumn 29, Issue 1, 2012, Pages 54-62

  Yamamoto, Hiromitsu ^a   Tahara, Kohei ^b,c   Kawashima, Yoshiaki ^a  

^a AICHI GAKUIN UNIVERSITY   (Japan)

^b NAGOYA CITY UNIVERSITY   (Japan)

^c GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Chitosan; Drug delivery; Nanoparticle; Oral administration; Poly(DL lactide co glycolide); Polysorbate 80; Surface modification

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NANOPARTICLE; NUCLEIC ACID; OLIGONUCLEOTIDE; POLYGLACTIN;

BIODEGRADABILITY; COLITIS; CYTOTOXICITY; DIFFUSION; DRUG DELIVERY SYSTEM; EMULSION; GENE TARGETING; HUMAN; MOLECULAR WEIGHT; NANOMEDICINE; NONHUMAN; REVIEW; SURFACE PROPERTY;

ADMINISTRATION, ORAL; BIOCOMPATIBLE MATERIALS; DIFFUSION; EMULSIONS; LACTIC ACID; NANOPARTICLES; NUCLEIC ACIDS; POLYGLYCOLIC ACID; SOLVENTS; SURFACE PROPERTIES;

EID: 84855875151     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2011.629745     Document Type: Review

References (67)

1. Alshamsan A, Haddadi A, Hamdy S, Samuel J, El-Kadi A, Uludag H, Lavasanifar A. STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anti-cancer immune response. Mol Pharmaceutics, 2010;7:1643-54.
2. Andersen MØ, Lichawska A, Arpanaei A, Rask Jensen SM, Kaur H, Oupicky D, Besenbacher F, Kingshott P, Kjems J, Howard KA. Surface functionalisation of PLGA nanoparticles for gene silencing. Biomaterials, 2010;31:5671-7.
3. Aouadi M, Tesz GJ, Nicoloro SM, Wang M, Chouinard M, Soto E, Ostroff GR, Czech MP. Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation. Nature, 2009;458:1180-4.
4. Baoum A, Dhillon N, Buch S, Berkland C. Cationic surface modification of PLG nanoparticles offers sustained gene delivery to pulmonary epithelial cells. J Pharm Sci, 2010;99:2413-22.
5. Basarkar A, Devineni D, Palaniappan R, Singh J. Preparation, characterization, cytotoxicity and transfection efficiency of poly(D-L-lactide-co-glycolide) and poly(D-L-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA. Int J Pharm, 2007;343:247-54. (Pubitemid 47334869)
6. Belbella A, Vauthier C, Fessi H, Devissaguet J-P, Puisieux F. In vitro degradation of nanospheres from poly(D,L-lactides) of different molecular weights and polydispersities. Int J Pharm, 1996;129:95-102. (Pubitemid 26097979)
7. Bhavsar M, Amiji M. Gastrointestinal distribution and in vivo gene trans-fection studies with nanoparticles-in-microsphere oral system (NiMOS). J Controlled Release, 2007;119:339-48. (Pubitemid 46770879)
8. Cartiera MS, Johnson KM, Rajendran V, Caplan MJ, Saltzman WM. The uptake and intracellular fate of PLGA nanoparticles in epithelial cells. Biomaterials, 2009;30:2790-8.
9. Chasin M, Langer R (eds.) 1990. Biodegradable polymers as drug delivery systems, drugs and pharmaceutical sciences. New York, NY: Marcel Dekker.
10. Cohen H, Levy R, Gao J, Fishbein I, Kousaev V, Sosnowski S, Slomkowski S, Golomb G. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles. Gene Ther, 2000;7:1896-905.
11. Couvreur P, Puisieux F. Nano- and microparticles for the delivery of polypeptides and proteins. Adv Drug Delivery Rev, 1993;10:141-62. (Pubitemid 23172580)
12. Cun D, Foged C, Yang M, Frøkjær S, Nielsen HM. Preparation and characterization of poly(dl-lactide-co-glycolide) nanoparticles for siRNA delivery. Int J Pharm, 2010;390:70-5.
13. Cun D, Jensen DK, Maltesen MJ, Bunker M, Whiteside P, Scurr D, Foged C, Nielsen HM. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: Quality by design optimization and characterization. Eur J Pharm Biopharm, 2011;77:26-35.
14. De Vry CG, Prasad S, Komuves L, Lorenzana C, Parham C, Le T, Adda S, Hoffman J, Kahoud N, Garlapati R, et al. Non-viral delivery of nuclear factor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis. Gut, 2007;56:524-33. (Pubitemid 46580509)
15. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 2001;411:494-8. (Pubitemid 32494397)
16. Fichtner-Feigl S, Fuss IJ, Preiss JC, Strober W, Kitani A. Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-kappa B decoy oligonucleotides. J Clin Invest, 2005; 115:3057-71. (Pubitemid 41567571)
17. Jain R. The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide)(PLGA) devices. Biomaterials, 2000;21:2475-90.
18. Jain A, Chasoo G, Singh SK, Saxena AK, Jain SK. Transferrin-appended PEGylated nanoparticles for temozolomide delivery to brain: In vitro-characterisation. J Microencapsul, 2011;28:21-8.
19. Katas H, Cevher E, Alpar HO. Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery. Int J Pharm, 2009;369:144-54.
20. Kawashima Y, Yamamoto H, Takeuchi H, Hino T, Niwa T. Properties of a peptide containing dl-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods. Eur J Pharm Biopharm, 1998;45:41-8. (Pubitemid 28248254)
21. Kim SH, Jeong JH, Chun KW, Park TG. Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate. Langmuir, 2005b;21:8852-7. (Pubitemid 41396646)
22. Kim I, Lee S-K, Park Y-M, Lee Y-B, Shin S-C, Lee KC, Oh I. Physicochemical characterization of poly(l-lactic acid) and poly(D,L-lactide-co- glycolide) nanoparticles with polyethylenimine as gene delivery carrier. Int J Pharm, 2005a;298:255-62. (Pubitemid 40828346)
23. Kreuter J. Peroral administration of nanoparticles. Adv Drug Delivery Rev, 1991;7:71-86.
24. Kriegel C, Amiji M. Oral TNF-a gene silencing using a polymeric micro-sphere-based delivery system for the treatment of inflammatory bowel disease. J Controlled Release, 2010;150:77-86.
25. Kumari A, Yadav SK. Cellular interactions of therapeutically delivered nanoparticles. Expert Opin Drug Deliv, 2011;8:141-51.
26. Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B, 2010;75:1-18.
27. Lambert G, Fattal E, Pinto-Alphandary H, Gulik A, Couvreur P. Polyisobutylcyanoacrylate nanocapsules containing an aqueous core for the delivery of oligonucleotides. Int J Pharm, 2001;214:13-16. (Pubitemid 32244070)
28. Mo Y, Lim LY. Mechanistic study of the uptake of wheat germ agglutinin-conjugated PLGA nanoparticles by A549 cells. J Pharm Sci, 2004;93:20-8. (Pubitemid 38081810)
29. Mo Y, Lim LY. Paclitaxel-loaded PLGA nanoparticles: Potentiation of anticancer activity by surface conjugation with wheat germ agglutinin. J Controlled Release, 2005;108:244-62. (Pubitemid 41608658)
30. Moret I, Esteban Peris J, Guillem VM, Benet M, Revert F, Dasi F, Crespo A, Alino SF. Stability of PEI-DNA and DOTAP-DNA complexes: Effect of alkaline pH, heparin and serum. J Controlled Release, 2001;76:169-81. (Pubitemid 32786894)
31. Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A, Maeda K, Sawa Y, Kaneda Y, Higaki J, et al. In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction. Nat Med, 1997;3:894-9. (Pubitemid 27353450)
32. Morishita R, Tomita N, Kaneda Y, Ogihara T. Molecular therapy to inhibit NFATB activation by transcription factor decoy oligonucleotides. Curr Opin Pharmacol, 2004;4:139-46. (Pubitemid 38444048)
33. Murakami H, Kobayashi M, Takeuchi H, Kawashima Y. Preparation of poly(-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. Int J Pharm, 1999;187:143-52. (Pubitemid 29443894)
34. Niven R, Zhang Y, Smith J. Toward development of a non-viral gene therapeutic. Adv Drug Deliv Rev, 1997;26:135-50. (Pubitemid 27289530)
35. Niwa T, Takeuchi H, Hino T, Kunou N, Kawashima Y. Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with D,L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior. J Controlled Release, 1993;25:89-98. (Pubitemid 23168633)
36. Owensiii D, Peppas N. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm, 2006;307:93-102. (Pubitemid 41773257)
37. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev, 2003a;55:329-47. (Pubitemid 36297053)
38. Panyam J, Labhasetwar V. Dynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharm Res, 2003b;20:212-20. (Pubitemid 36277684)
39. Panyam J, Zhou WZ, Prabha S, Sahoo SK, Labhasetwar V. Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: Implications for drug and gene delivery. FASEB J, 2002;16:1217-26. (Pubitemid 34815409)
40. Patil Y, Panyam J. Polymeric nanoparticles for siRNA delivery and gene silencing. Int J Pharm, 2009;367:195-203.
41. Prabha S, Zhou W-Z, Panyam J, Labhasetwar V. Size-dependency of nano-particle-mediated gene transfection: Studies with fractionated nanoparticles. Int J Pharm, 2002;244:105-15. (Pubitemid 35245451)
42. Qaddoumi MG, Ueda H, Yang J, Davda J, Labhasetwar V, Lee VHL. The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers. Pharm Res, 2004;21:641-8. (Pubitemid 38457287)
43. Roy K, Mao HQ, Huang SK, Leong KW. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med, 1999;5:387-91. (Pubitemid 29180575)
44. Sahoo SK, Labhasetwar V. Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol. Pharm, 2005;2:373-83. (Pubitemid 41503678)
45. Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Controlled Release, 2002;82:105-14. (Pubitemid 34775052)
46. Sneh-Edri H, Stepensky D. 'IntraCell' plugin for assessment of intracellular localization of nano-delivery systems and their targeting to the individual organelles. Biochem Biophys Res Commun, 2011;405:228-33.
47. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Controlled Release, 2001;70:1-20. (Pubitemid 32144788)
48. Spenlehauer G, Vert M, Benoit JP, Boddaert A. In vitro and in vivo degradation of poly(D,L lactide/glycolide) type microspheres made by solvent evaporation method. Biomaterials, 1989;10:557-63.
49. Sun S, Liang N, Piao H, Yamamoto H, Kawashima Y, Cui F. Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: Formulation, characterization and in vivo evaluation. J Microencapsul, 2010;27:471-8.
50. Tahara K, Furukawa S, Yamamoto H, Kawashima Y. Hybrid-modified poly(D,L-lactide-co-glycolide) nanospheres for a novel cellular drug delivery system. Int J Pharm, 2010a;392:311-13.
51. Tahara K, Kato Y, Yamamoto H, Kreuter J, Kawashima Y. Intracellular drug delivery using polysorbate 80-modified poly(D,L-lactide-co-glycolide) nanospheres to glioblastoma cells. J Microencapsul, 2011a; 28:29-36.
52. Tahara K, Sakai T, Yamamoto H, Takeuchi H, Hirashima N, Kawashima Y. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells. Int J Pharm, 2009;382:198-204.
53. Tahara K, Sakai T, Yamamoto H, Takeuchi H, Hirashima N, Kawashima Y. Improvements in transfection efficiency with chitosan modified PLGA nanospheres prepared by the emulsion solvent diffusion method, for gene delivery. Chem Pharm Bull (Tokyo), 2011b;59:1-6.
54. Tahara K, Sakai T, Yamamoto H, Takeuchi H, Kawashima Y. Establishing chitosan coated PLGA nanosphere platform loaded with wide variety of nucleic acid by complexation with cationic compound for gene delivery. Int J Pharm, 2008;354:210-6.
55. Tahara K, Samura S, Tsuji K, Yamamoto H, Tsukada Y, Bando Y, Tsujimoto H, Morishita R, Kawashima Y. Oral nuclear factor-kappaB decoy oligonucleotides delivery system with chitosan modified poly(D,L-lactide-co-glycolide) nanospheres for inflammatory bowel disease. Biomaterials, 2011c;32:870-8.
56. Tahara K, Yamamoto H, Hirashima N, Kawashima Y. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects. Eur J Pharm Biopharm, 2010b;74:421-6.
57. Tahara K, Yamamoto H, Kawashima Y. Cellular uptake mechanisms and intracellular distributions of polysorbate 80-modified poly (D,L-lactide-co- glycolide) nanospheres for gene delivery. Eur J Pharm Biopharm, 2010c;75:218-24.
58. Takeuchi H, Yamamoto H, Kawashima Y. Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv Drug Delivery Rev, 2001;47:39-54. (Pubitemid 32209231)
59. Vauthier C, Dubernet C, Fattal E, Pinto-Alphandary H, Couvreur P. Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. Adv Drug Delivery Rev, 2003;55:519-48. (Pubitemid 36423302)
60. Wang D, Robinson DR, Kwon GS, Samuel J. Encapsulation of plasmid DNA in biodegradable poly(D, L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery. J Controlled Release, 1999; 57:9-18. (Pubitemid 29005068)
61. Weissenbock A, Wirth M, Gabor F. WGA-grafted PLGA-nanospheres: Preparation and association with Caco-2 single cells. J Controlled Release, 2004;99:383-92. (Pubitemid 39296907)
62. Wilson DS, Dalmasso G, Wang L, Sitaraman SV, Merlin D, Murthy N. Orally delivered thioketal nanoparticles loaded with TNF-a-siRNA target inflammation and inhibit gene expression in the intestines. Nat Mater, 2010;9:923-8.
63. Woodrow KA, Cu Y, Booth CJ, Saucier-Sawyer JK, Wood MJ, Saltzman WM. Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA. Nat Mater, 2009;8:526-33.
64. Xiang JY, Wu LG, Huang XL, Zhang M, Pen L, Ouyan Q, Gan HT. Amelioration of murine dextran sulfate sodium-induced colitis by nuclear factor-Arb decoy oligonucleotides. Am J Surg, 2009;197:797-805.
65. Yamamoto H, Kuno Y, Sugimoto S, Takeuchi H, Kawashima Y. Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. J Controlled Release, 2005;102:373-81. (Pubitemid 40093760)
66. Yuan X, Shah BA, Kotadia NK, Li J, Gu H, Wu Z. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery. Pharm Res, 2010; 27:1285-95.
67. Zhang Z, Huey Lee S, Feng S-S. Folate-decorated poly(lactide-co-glyco- lide)-vitamin E TPGS nanoparticles for targeted drug delivery. Biomaterials, 2007;28:1889-99. (Pubitemid 46137995)